Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia | Zendy

Oliver A. Cornely | Zendy; Thibaut Leguay | Zendy; Johan Maertens | Zendy; Maria J. G. T. Vehreschild | Zendy; Αchilles Anagnostopoulos | Zendy; Carlo Castagnola | Zendy; Luisa Verga | Zendy; Christina Rieger | Zendy; Mustafa Kondakci | Zendy; Georg Härter | Zendy; Rafael F. Duarte | Zendy; Bernardino Allione | Zendy; Catherine Cordonnier | Zendy; Claus Peter Heußel | Zendy; C. Orla Morrissey | Zendy; Samir Agrawal | Zendy; J. Peter Donnelly | Zendy; Mark Bresnik | Zendy; Michael Hawkins | Zendy; Will Garner | Zendy; Nicola Gökbuget | Zendy

Open Access

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

Author(s) -

Oliver A. Cornely,

Thibaut Leguay,

Johan Maertens,

Maria J. G. T. Vehreschild,

Αchilles Anagnostopoulos,

Carlo Castagnola,

Luisa Verga,

Christina Rieger,

Mustafa Kondakci,

Georg Härter,

Rafael F. Duarte,

Bernardino Allione,

Catherine Cordonnier,

Claus Peter Heußel,

C. Orla Morrissey,

Samir Agrawal,

J. Peter Donnelly,

Mark Bresnik,

Michael Hawkins,

Will Garner,

Nicola Gökbuget

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx133

Subject(s) - placebo , medicine , tolerability , clinical endpoint , chemotherapy , regimen , amphotericin b , surgery , randomization , induction chemotherapy , gastroenterology , adverse effect , randomized controlled trial , pathology , antifungal , alternative medicine , dermatology

To prevent invasive fungal disease (IFD) in adult patients undergoing remission-induction chemotherapy for newly diagnosed acute lymphoblastic leukaemia (ALL).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research